In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma

Nuclear Medicine Communications

Volumn 23, Issue 10, 2002, Pages 983-989

  Juweid, M E ^a   Menda, Y ^a   O'DORISIO, M S ^b   Bushnell, D ^b   Blake, M ^b   Madsen, M ^b   Johnson, J ^b   Graham, M M ^b  

^a Department of Radiology and Division of Pediatric Oncology ^*  (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Bone metastases; Bone scintigraphy; In pentetreotide scintigraphy; Neuroblastoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 125; (3 IODOBENZYL)GUANIDINE I 131; MEDRONATE TECHNETIUM TC 99M; PENTETREOTIDE IN 111; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; DTPA PENTETREOTIDE; FLUORODEOXYGLUCOSE F 18; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BONE BIOPSY; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER STAGING; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; BONE; BONE TUMOR; BRAIN TUMOR; FOLLOW UP; METASTASIS; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; BONE AND BONES; BONE NEOPLASMS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROBLASTOMA; PENTETIC ACID; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036794707     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200210000-00008     Document Type: Article

References (20)

1. Bousvaros A, Kirks DR, Grossman H. Imaging of neuroblastoma; an overview. Pediatr Radiol 1986; 16: 89-106.
2. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11: 1466-1477.
3. Gelfand M. Meta-iodobenzylguanidine in children. Semin Nucl Med 1993; 23: 231-242.
4. Shulkin BL, Shapiro B, Hutchinson RJ. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for thedetection of neuroblastoma. J Nucl Med 1992; 33: 1735-1740.
5. Englaro EE, Gelfand MJ, Harris RE, et al. I-131 MIBG imaging after bone marrow transplantation for neuroblastoma. Radiology 1992; 182: 515-520.
6. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
7. Manil L, Edeline V, Lumbroso J, et al. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. J Nucl Med 1996; 37: 893-896.
8. Kropp J, Hofmann M, Bihl H. Comparison of MIBG and pentetreotide scintigraphy in children with neuroblastoma. Is the expression of somatostatin receptors a prognostic factor? Anticancer Res 1997; 17: 1583-1588.
9. Shalaby-Rana E, Majd M, Andrich MP, et al. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-myc oncogene amplification, and patient outcome. Clin Nucl Med 1997; 22: 315-319.
10. Limouris GS, Giannakopoulos V, Stavraka A, et al. Comparison of In-111 pentetreotide, Tc-99m (V) DMSA and I-123 MIBG scintimaging in neural crest tumors. Anticancer Res 1997; 17: 1589-1592.
11. O'Dorisio SM, Chen F, Qualman SJ, et al. Somatostatin receptors (SMS-R) expression in neuroblastoma tumors. Regul Peptides 1992; 40: 220- (abstract).
12. Gordon I, Peters AM, Gutman A, et al. Tc-99m bone scans are more sensitive than I-123 MIBG scans for bone imaging in neuroblastoma. J Nucl Med 1990; 31: 129-134.
13. Briganti V, Sestini R, Orlando C, et al. Imaging of somatostatin receptors by Indium-111 pentetreotide with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors. Clin Can Res 1997; 3: 2385-2391.
14. Moertel CL, Reubi JC, Scheithauer B, Schaid DJ, Kvols LK. Expression of somatostatin receptors in childhood neuroblastoma. Am J Clin Pathol 1994; 102: 752-756.
15. O'Dorisio SM, Chen F, O'Dorisio TM, Wray D, Qualman SJ. Characterization of somatostatin receptors in human neuroblastoma tumors. Cell Growth Differ 1994; 5: 1-8.
16. Donohoe KJ, Henkin RE, Royal HD, et al. Procedure guideline for bone scintigraphy: 1.0. Society of Nuclear Medicine. J Nucl Med 1996; 37: 1903-1906.
17. Seabold JE, Forstorm LA, Schauwecker DS, et al. Procedure guideline for In-111 leukocyte scintigraphy for suspected infection/inflammation. J Nucl Med 1997; 38: 997-1001.
18. Balon HR, Goldsmith SJ, Siegel BA, et al. Procedure guideline for somatostatin receptor scintigraphy with In-111 pentetreotide. J Nucl Med 2001; 42: 1134-1138.
19. ICRP Publication 53. Biokinetic models, absorbed doses and effective doses equivalent for individual radiopharmaceuticals. Ann ICRP 1987; 18: 329-331.
20. Bartold SP, Donohoe KJ, Fletcher JW, et al. Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. Society of Nuclear Medicine. J Nucl Med 1997; 38: 990-994.